Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

<h4>Background</h4>There is little consensus, and minimal evidence, regarding the age at which to stop cervical screening. We studied the association between screening at age 50-64 y and cervical cancer at age 65-83 y.<h4>Methods and findings</h4>Cases were women (n = 1,341)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alejandra Castañón, Rebecca Landy, Jack Cuzick, Peter Sasieni
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Acceso en línea:https://doaj.org/article/eb116b52f12e41ea924ed58703080786
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb116b52f12e41ea924ed58703080786
record_format dspace
spelling oai:doaj.org-article:eb116b52f12e41ea924ed587030807862021-11-18T05:43:00ZCervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.1549-12771549-167610.1371/journal.pmed.1001585https://doaj.org/article/eb116b52f12e41ea924ed587030807862014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24453946/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>There is little consensus, and minimal evidence, regarding the age at which to stop cervical screening. We studied the association between screening at age 50-64 y and cervical cancer at age 65-83 y.<h4>Methods and findings</h4>Cases were women (n = 1,341) diagnosed with cervical cancer at age 65-83 y between 1 April 2007 and 31 March 2012 in England and Wales; age-matched controls (n = 2,646) were randomly selected from population registers. Screening details from 1988 onwards were extracted from national databases. We calculated the odds ratios (OR) for different screening histories and subsequent cervical cancer. Women with adequate negative screening at age 65 y (288 cases, 1,395 controls) were at lowest risk of cervical cancer (20-y risk: 8 cancers per 10,000 women) compared with those (532 cases, 429 controls) not screened at age 50-64 y (20-y risk: 49 cancers per 10,000 women, with OR = 0.16, 95% CI 0.13-0.19). ORs depended on the age mix of women because of the weakening association with time since last screen: OR = 0.11, 95% CI 0.08-0.14 at 2.5 to 7.5 y since last screen; OR = 0.27, 95% CI 0.20-0.36 at 12.5 to 17.5 y since last screen. Screening at least every 5.5 y between the ages 50 and 64 y was associated with a 75% lower risk of cervical cancer between the ages 65 and 79 y (OR = 0.25, 95% CI 0.21-0.30), and the attributable risk was such that in the absence of screening, cervical cancer rates in women aged 65+ would have been 2.4 (95% CI 2.1-2.7) times higher. In women aged 80-83 y the association was weaker (OR = 0.49, 95% CI 0.28-0.83) than in those aged 65-69 y (OR = 0.12, 95% CI 0.09-0.17). This study was limited by an absence of data on confounding factors; additionally, findings based on cytology may not generalise to human papillomavirus testing.<h4>Conclusions</h4>Women with adequate negative screening at age 50-64 y had one-sixth of the risk of cervical cancer at age 65-83 y compared with women who were not screened. Stopping screening between ages 60 and 69 y in women with adequate negative screening seems sensible, but further screening may be justifiable as life expectancy increases.Alejandra CastañónRebecca LandyJack CuzickPeter SasieniPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 11, Iss 1, p e1001585 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Alejandra Castañón
Rebecca Landy
Jack Cuzick
Peter Sasieni
Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
description <h4>Background</h4>There is little consensus, and minimal evidence, regarding the age at which to stop cervical screening. We studied the association between screening at age 50-64 y and cervical cancer at age 65-83 y.<h4>Methods and findings</h4>Cases were women (n = 1,341) diagnosed with cervical cancer at age 65-83 y between 1 April 2007 and 31 March 2012 in England and Wales; age-matched controls (n = 2,646) were randomly selected from population registers. Screening details from 1988 onwards were extracted from national databases. We calculated the odds ratios (OR) for different screening histories and subsequent cervical cancer. Women with adequate negative screening at age 65 y (288 cases, 1,395 controls) were at lowest risk of cervical cancer (20-y risk: 8 cancers per 10,000 women) compared with those (532 cases, 429 controls) not screened at age 50-64 y (20-y risk: 49 cancers per 10,000 women, with OR = 0.16, 95% CI 0.13-0.19). ORs depended on the age mix of women because of the weakening association with time since last screen: OR = 0.11, 95% CI 0.08-0.14 at 2.5 to 7.5 y since last screen; OR = 0.27, 95% CI 0.20-0.36 at 12.5 to 17.5 y since last screen. Screening at least every 5.5 y between the ages 50 and 64 y was associated with a 75% lower risk of cervical cancer between the ages 65 and 79 y (OR = 0.25, 95% CI 0.21-0.30), and the attributable risk was such that in the absence of screening, cervical cancer rates in women aged 65+ would have been 2.4 (95% CI 2.1-2.7) times higher. In women aged 80-83 y the association was weaker (OR = 0.49, 95% CI 0.28-0.83) than in those aged 65-69 y (OR = 0.12, 95% CI 0.09-0.17). This study was limited by an absence of data on confounding factors; additionally, findings based on cytology may not generalise to human papillomavirus testing.<h4>Conclusions</h4>Women with adequate negative screening at age 50-64 y had one-sixth of the risk of cervical cancer at age 65-83 y compared with women who were not screened. Stopping screening between ages 60 and 69 y in women with adequate negative screening seems sensible, but further screening may be justifiable as life expectancy increases.
format article
author Alejandra Castañón
Rebecca Landy
Jack Cuzick
Peter Sasieni
author_facet Alejandra Castañón
Rebecca Landy
Jack Cuzick
Peter Sasieni
author_sort Alejandra Castañón
title Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
title_short Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
title_full Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
title_fullStr Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
title_full_unstemmed Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
title_sort cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/eb116b52f12e41ea924ed58703080786
work_keys_str_mv AT alejandracastanon cervicalscreeningatage5064yearsandtheriskofcervicalcanceratage65yearsandolderpopulationbasedcasecontrolstudy
AT rebeccalandy cervicalscreeningatage5064yearsandtheriskofcervicalcanceratage65yearsandolderpopulationbasedcasecontrolstudy
AT jackcuzick cervicalscreeningatage5064yearsandtheriskofcervicalcanceratage65yearsandolderpopulationbasedcasecontrolstudy
AT petersasieni cervicalscreeningatage5064yearsandtheriskofcervicalcanceratage65yearsandolderpopulationbasedcasecontrolstudy
_version_ 1718424825597263872